PATENT CLAIM ANALYSIS

Application Number: 16079589
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["424", "489000"]

Abstract:
The present invention provides a pharmaceutical composition containing a pyrrolo-fused six-membered heterocyclic compound or a pharmaceutically acceptable salt of the compound. Specifically, the invention provides a pharmaceutical composition containing 5-(2-diethylamino-ethyl)-2-(5-fluoro-2-oxo-1,2-dihydro-indol-3-ylidene-methyl)-3-methyl-1,5,6,7-tetrahydro-pyrrolo[3,2-c]pyridin-4-one or a pharmaceutically acceptable salt thereof, and at least one water soluble filler. The pharmaceutical composition of the invention features a rapid dissolution and good stability.

Claim (Index 4):
The pharmaceutical composition according to  claim 1 , wherein the composition has a dissolution rate greater than or equal to 80% in 45 minutes, wherein the dissolution rate is determined according to the second method of general rule 0931 of volume IV of Chinese Pharmacopoeia 2015 Edition, and wherein the method uses purified water as a dissolution medium at 37\u00b10.5\u00b0 C. and at a paddle speed of 50 rpm.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 96.0
- Lexical Diversity: 1.62222
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16077610', '13142116', '16343171', '12993629', '13703120']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7552851762109968
- 35 USC 102 Novelty (BERT): 0.5146541542754232
- Combined Prediction Score: 0.7312220740174394
- Mean Citation Score: 257.427704
- Max Citation Score: 281.33914
- Similarity Product: 184.5379555355429

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test